Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $1,135.5, with a 24-hour trading volume of $2.21B. The asset's market cap is $1.01T, after moving -2.41% in the last day.
Tokenized Eli Lilly And Co is trading at $1,139.57, with a tokenized market cap of $43.91M and a 24-hour trading volume of $2.79M. The tokenized asset has moved -1.69% in the past 24 hours.